F
Foundayo
Productby Eli Lilly and Company
Heard in 7 episodes across 6 shows since Apr 2026
Foundayo is a brand name for tirzepatide, Eli Lilly’s prescription medicine marketed for chronic weight management.
Episodes
7
across 6 shows
First heard
Apr 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
1
2
3
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 1 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 1 |
| Sep 2026 | 0 |
| Oct 2026 | 2 |
| Nov 2026 | 3 |
Email alert
Email me when Foundayo comes up on a podcast
One email a week at most, with the new episodes that mention Foundayo. Free, no account needed, unsubscribe in one click.
Episodes
7 episodes featuring Foundayo, newest first
- Nov 9, 2026
Nvidia stumbles as investors rotate beyond AIClosing BellNov 9, 2026 - Nov 9, 2026
Nvidia’s China exposure collides with national-security scrutinyClosing BellNov 9, 2026 - Nov 9, 2026
NVIDIA faces governance risk as Tesla pivots to robotaxisBrew MarketsNov 9, 2026 - Oct 29, 2026
Software weakness sends Nasdaq lower as stock setups divergeStock Market Today With IBDOct 29, 2026 - Oct 20, 2026
Markets weigh Netflix weakness against AI infrastructure ambitionsCNBC's "Fast Money"Oct 20, 2026 - Aug 5, 2026
AI spending lifts Lilly while dialysis miss hits DaVitaStock MoversAug 5, 2026